Development of stable HEK293T cell pools expressing CSFV E2 protein: A potential antigen expression platform. Issue 9 (24th February 2023)

• Record Type: Journal Article
• Authors: Zhang, Yanmin; Na, Daoyuan; Zhang, Weijian; Liu, Xuping; Miao, Shiwei; Tan, Wen-Song; Zhao, Liang
• Is Part Of: Vaccine. Volume 41:Issue 9(2023)
• Page Start: 1573
• Page End: 1583
• Publication Date: 2023-02-24
• Subjects: HEK293T cell pools -- CSFV E2 protein -- Signal peptides -- Cultivation methods -- Antigens; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2023.01.038
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: Large quantities of antigens are required since protective antigens, such as classical swine fever virus (CSFV) E2 protein, are widely used in diagnostic reagents and subunit vaccines. Compared to clonal cell lines and transient gene expression, stable cell pools provide a potential alternative platform to rapidly produce large amounts of antigens. In this work, firstly, Human embryonic kidney 293 T (HEK293T) cell pools expressing E2 protein were developed by transduction of lentiviral vectors. On the one hand, the SP7 was selected from 7 well-performing signal peptides to remarkably increase the production of E2 protein. On the other hand, it was found that high MOI could improve the expression of E2 protein by increasing gene copy numbers. Moreover, the HEK293T cell pools were evaluated for stability by passages and batch cultures, demonstrating that the cell pools were stable for at least 90 days. And then, the performance of the cell pools in batch, fed-batch, and semi-perfusion was studied. Among them, the titer of E2 protein was up to 2 g/L in semi-perfusion, which is currently the highest to the authors' knowledge. Finally, the aggregations and immunogenicity of the E2 protein were analyzed by SDS-PAGE and immunization of mice, respectively. There was no significant difference in aggregations and antibody titers of E2 protein in three culture methods. These results suggest that stable HEK293T cell pools are a promising and robust platform for rapid and efficient production of recombinant proteins.